Login to Your Account

Royalty Pharma Increases Its Bid for Elan to $7.3B

By Cormac Sheridan
Staff Writer

Wednesday, April 17, 2013
DUBLIN, Ireland – Royalty Pharma upped the ante in its efforts to land Elan Corp. plc by raising its bid to $12 per share, an offer that values the Dublin, Ireland-based biotech at around $7.3 billion.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription